HIV patients with moderate immune suppression at greater risk of severe COVID-19 breakthrough infection

People with HIV who have moderate immune suppression appear to be at greater risk of severe COVID-19 "breakthrough" infection after vaccination, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

Related Keywords

United States ,American ,Keri Althoff ,Celeena Jefferson ,Emily Henderson ,Amy Justice ,Lindsay Browne ,Sonia Napravnik ,Kathleen Akg ,Brenna Hogan ,Vincent Marconi ,Jessie Edwards ,Lily Fathi ,Jacek Scarbinski ,Atlantic States ,Michael Silverberg ,Wendy Leyden ,Cameron Stewart ,Sally Coburn ,Eric Watson ,Elizabeth Humes ,Kelly Gebo ,Kirsha Gordon ,Michael Horburg ,Carolyn Williams ,Centers For Disease ,Bloomberg School ,Cumming School Of Medicine ,National Institute Of Allergy ,National Institutes Of Health ,University Of North Carolina ,Veterans Health Administration ,Virus Epidemiology Team ,Department Of Epidemiology ,University Of Calgary ,Johns Hopkins Bloomberg School Of Public Health ,Department Of Medicine ,Cohort Collaboration On Research ,Johns Hopkins Bloomberg School ,Study Senior Author ,Associate Professor ,Disease Control ,Corona Infectious Virus Epidemiology Team ,Kaiser Permanente Mid Atlantic States ,Kaiser Permanente Northern California ,Raynell Lang ,Cumming School ,Severe Illness After Post Vaccination ,Among Adults With ,Lesley Park ,Deana Agil ,North American ,National Institute ,Infectious Diseases ,National Institutes ,Cd4 ,Fell ,Covid 19 ,Shiv ,Flood ,Epidemiology ,Medicine ,Public Health ,Research ,Vaccine ,